Our mission

Accelerate and maximize the chance of success of projects exploiting the potential of our biopolymers in new applications meeting high unmet medical needs.


We offer :

  • Financial support through seeds round, series A
  • Biopolymers science
  • Biopolymers CMC expertise
  • Connection to strategics and KOL network
  • Market intelligence and strategic advisory

Which projects can apply


  • Developing Rx drug products or medical devices at non-clinical stages or GMP technologies
  • With a first in vivo proof of concept
  • Located around the world
  • Seeking financial and technical support
  • Looking for business collaboration with HTL
  • Opening doors to biopolymers in new medical sectors: drug delivery, regenerative medicine, prosthetics and implants, oncology, nephrology…
  • Developing new benefits in HTL’s major applications: ophthalmology, reconstructive medicine, dermatology, rheumatology, bio-production…


Apply now

Working Together

Collaboration with HTL, a long-standing partner to the pharmaceutical and medical device industries worldwide, opens the door to faster business development.
HTL aims to have an impact on its portfolio companies, not only as a financial supporter, but also as a scientific, technical, industrial, commercial and strategic advisor.

Apply now


Discover our
first investment

In March 2022, HTL announced its incubator’s equity investment in GelMEDIX, an early-stage biotech engineering ocular cell therapies to restore vision for patients suffering from blindness.

HTL provide financial, industrial and scientific support to GelMEDIX to facilitate the development of new solutions based on its proprietary hydrogel platform.

Learn more about it

A diversified team for a 360°
project support

Valentin Fleury

Head of the Start-up Funding program
Strategy and Transformation Manager

Bertrand Hurtault

Chief Strategy & Transformation Officer

François Fournier

Chief Executive Officer

Nicolas Prefol

Chief Financial Officer

Caroline Robic

Innovation Director

Paul Navarre

Chairman of the Board of Directors at HTL